Literature DB >> 16762799

Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.

Jonathan A Hata1, Matthew L Williams, Jacob N Schroder, Brian Lima, Janelle R Keys, Burns C Blaxall, Jason A Petrofski, Andre Jakoi, Carmelo A Milano, Walter J Koch.   

Abstract

BACKGROUND: In human heart failure, increased expression of G protein-coupled receptor kinases (GRKs) causes the loss of beta-adrenergic receptor (betaAR) signaling and function. Mechanical unloading with a left ventricular assist device (LVAD) promotes reverse remodeling, which includes restoration of betaAR responsiveness. We tested the hypothesis that LVAD support of the failing human heart alters the expression and activity of GRKs and we sought to determine whether changes in myocardial GRKs could be tracked in lymphocytes. METHODS AND
RESULTS: Paired samples of human LV tissue (n = 12) and blood were obtained at the time of LVAD implantation (heart failure) and subsequent cardiac transplantation (LVAD). betaAR signaling was quantified by receptor density and adenylyl cyclase activity. Immunoblotting and real-time reverse transcription polymerase chain reaction were used to measure GRK2 and GRK5 protein and mRNA levels. Rhodopsin phosphorylation was used to assess total GRK activity. Consistent with reverse remodeling, betaAR density and signaling were restored to nonfailing levels after LVAD support. GRK2 protein levels were significantly reduced 55% after LVAD support and GRK2 mRNA was similarly reduced. In contrast, GRK5 protein and mRNA levels were unchanged. Total myocardial GRK activity was reduced similar to the drop in GRK2 expression. In lymphocytes, GRK2 protein levels were decreased after LVAD support and there was a significant positive correlation between myocardial and lymphocyte GRK2 levels in both heart failure and LVAD samples.
CONCLUSION: The changes in myocardial GRK2 expression and activity that are mirrored in lymphocytes provide a possible mechanism for the restoration of betaAR signaling and reverse remodeling after mechanical unloading in the failing heart. Moreover, lymphocytes may provide a surrogate marker of myocardial GRK2 in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762799     DOI: 10.1016/j.cardfail.2006.02.011

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  38 in total

1.  Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity.

Authors:  Sharon Etzion; Yoram Etzion; Brian DeBosch; Peter A Crawford; Anthony J Muslin
Journal:  J Mol Cell Cardiol       Date:  2010-08-20       Impact factor: 5.000

2.  A kinetic model for calcium dynamics in RAW 264.7 cells: 2. Knockdown response and long-term response.

Authors:  Mano Ram Maurya; Shankar Subramaniam
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

Review 3.  GRK mythology: G-protein receptor kinases in cardiovascular disease.

Authors:  Gerald W Dorn
Journal:  J Mol Med (Berl)       Date:  2009-02-20       Impact factor: 4.599

4.  Effects and mechanism of Weinaokang on reperfusion-induced vascular injury to cerebral microvessels after global cerebral ischemia.

Authors:  Yong-qiu Zheng; Jian-xun Liu; Xin-zhi Li; Li Xu
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978

Review 5.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

6.  RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism.

Authors:  Yue Yi Wang; Pietro Mesirca; Elena Marqués-Sulé; Alexandra Zahradnikova; Olivier Villejoubert; Pilar D'Ocon; Cristina Ruiz; Diana Domingo; Esther Zorio; Matteo E Mangoni; Jean-Pierre Benitah; Ana María Gómez
Journal:  JCI Insight       Date:  2017-04-20

Review 7.  betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease.

Authors:  Henriette Brinks; Walter J Koch
Journal:  J Cardiovasc Transl Res       Date:  2010-07-10       Impact factor: 4.132

8.  Dynamic changes in lymphocyte GRK2 levels in cardiac transplant patients: a biomarker for left ventricular function.

Authors:  Raphael E Bonita; Philip W Raake; Nicholas J Otis; J Kurt Chuprun; Talya Spivack; Abhijit Dasgupta; David J Whellan; Paul J Mather; Walter J Koch
Journal:  Clin Transl Sci       Date:  2010-02       Impact factor: 4.689

9.  Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure.

Authors:  Liam M Casey; Andrew R Pistner; Stephen L Belmonte; Dmitriy Migdalovich; Olga Stolpnik; Frances E Nwakanma; Gabriel Vorobiof; Olga Dunaevsky; Alessandra Matavel; Coeli M B Lopes; Alan V Smrcka; Burns C Blaxall
Journal:  Circ Res       Date:  2010-06-24       Impact factor: 17.367

10.  Genetic deletion of Rnd3/RhoE results in mouse heart calcium leakage through upregulation of protein kinase A signaling.

Authors:  Xiangsheng Yang; Tiannan Wang; Xi Lin; Xiaojing Yue; Qiongling Wang; Guoliang Wang; Qin Fu; Xun Ai; David Y Chiang; Christina Y Miyake; Xander H T Wehrens; Jiang Chang
Journal:  Circ Res       Date:  2014-10-27       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.